secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001641172-25-015571
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma reduces stockholder meeting quorum to one-third
----------------------------------------------------------------

- Board approved bylaw amendment on June 17, 2025 reducing quorum to one-third of voting power.
- Quorum now requires one-third of outstanding shares entitled to vote, down from majority.
- Amendment effective immediately; full text filed as Exhibit 3.1.
- No other changes to bylaws or fiscal year were made.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225015571/0001641172-25-015571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225015571/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer